Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE‐158 study
Do-Youn Oh
1, 2
,
Alain Algazi
3
,
Jaume Capdevila
4, 5
,
Federico Longo
6
,
Wilson Miller
7, 8, 9
,
Jerry Tan Chun Bing
10
,
Carlos Eduardo Bonilla
11, 12
,
Hyun Ung Chung
13
,
Tormod K Guren
14
,
Chia-Chi Lin
15
,
Daniel Motola-Kuba
16
,
Manisha Shah
17
,
Julien Hadoux
18
,
Lili Yao
19
,
Jin Fan
19
,
Kevin Norwood
19
,
Loïc Lebellec
20
4
6
7
Segal Cancer Centre Jewish General Hospital Rossy Cancer Network Montreal Quebec Canada
|
10
Cebu Doctors University Hospital Cebu City Province of Cebu Philippines
|
12
Fundacion CTIC (Centro de Tratamiento e Investigación sobre Cáncer) Bogotá Colombia
|
16
COMOP A.C., Clinical Investigation Mexico City Mexico
|
19
Merck & Co., Inc. Rahway New Jersey USA
|
20
Centre Oscar Lambret Lille France
|
Тип публикации: Journal Article
Дата публикации: 2023-02-07
scimago Q1
wos Q1
БС1
SJR: 2.947
CiteScore: 11.5
Impact factor: 5.1
ISSN: 0008543X, 10970142
PubMed ID:
36748723
Cancer Research
Oncology
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Топ-30
Журналы
|
1
2
|
|
|
Oncology Letters
2 публикации, 5.71%
|
|
|
Journal for ImmunoTherapy of Cancer
2 публикации, 5.71%
|
|
|
International Journal of Molecular Sciences
2 публикации, 5.71%
|
|
|
Cancers
2 публикации, 5.71%
|
|
|
Frontiers in Immunology
2 публикации, 5.71%
|
|
|
Frontiers in Endocrinology
1 публикация, 2.86%
|
|
|
Angewandte Nuklearmedizin
1 публикация, 2.86%
|
|
|
JCO Oncology Practice
1 публикация, 2.86%
|
|
|
Tumor Diagnostik und Therapie
1 публикация, 2.86%
|
|
|
Current Opinion in Endocrine and Metabolic Research
1 публикация, 2.86%
|
|
|
Asia-Pacific Journal of Clinical Oncology
1 публикация, 2.86%
|
|
|
Experimental Cell Research
1 публикация, 2.86%
|
|
|
British Journal of Surgery
1 публикация, 2.86%
|
|
|
JAMA Oncology
1 публикация, 2.86%
|
|
|
Bulletin du Cancer
1 публикация, 2.86%
|
|
|
Endocrine Pathology
1 публикация, 2.86%
|
|
|
JCEM Case Reports
1 публикация, 2.86%
|
|
|
SAGE Open Medical Case Reports
1 публикация, 2.86%
|
|
|
Frontiers in Genetics
1 публикация, 2.86%
|
|
|
Annales d'Endocrinologie
1 публикация, 2.86%
|
|
|
Oral Oncology
1 публикация, 2.86%
|
|
|
Journal of International Medical Research
1 публикация, 2.86%
|
|
|
Biochimica et Biophysica Acta - Reviews on Cancer
1 публикация, 2.86%
|
|
|
Chinese Clinical Oncology
1 публикация, 2.86%
|
|
|
Cancer Treatment Reviews
1 публикация, 2.86%
|
|
|
ESMO Open
1 публикация, 2.86%
|
|
|
Thyroid
1 публикация, 2.86%
|
|
|
1
2
|
Издатели
|
1
2
3
4
5
6
7
8
|
|
|
Elsevier
8 публикаций, 22.86%
|
|
|
Frontiers Media S.A.
4 публикации, 11.43%
|
|
|
MDPI
4 публикации, 11.43%
|
|
|
Spandidos Publications
2 публикации, 5.71%
|
|
|
Georg Thieme Verlag KG
2 публикации, 5.71%
|
|
|
Springer Nature
2 публикации, 5.71%
|
|
|
BMJ
2 публикации, 5.71%
|
|
|
SAGE
2 публикации, 5.71%
|
|
|
American Society of Clinical Oncology (ASCO)
1 публикация, 2.86%
|
|
|
Wiley
1 публикация, 2.86%
|
|
|
Oxford University Press
1 публикация, 2.86%
|
|
|
American Medical Association (AMA)
1 публикация, 2.86%
|
|
|
The Endocrine Society
1 публикация, 2.86%
|
|
|
IntechOpen
1 публикация, 2.86%
|
|
|
AME Publishing Company
1 публикация, 2.86%
|
|
|
Mary Ann Liebert
1 публикация, 2.86%
|
|
|
1
2
3
4
5
6
7
8
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
35
Всего цитирований:
35
Цитирований c 2024:
32
(91.43%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Oh D. et al. Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE‐158 study // Cancer. 2023. Vol. 129. No. 8. pp. 1195-1204.
ГОСТ со всеми авторами (до 50)
Скопировать
Oh D., Algazi A., Capdevila J., Longo F., Miller W., Chun Bing J. T., Bonilla C. E., Chung H. U., Guren T. K., Lin C., Motola-Kuba D., Shah M., Hadoux J., Yao L., Jin Fan, Norwood K., Lebellec L. Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE‐158 study // Cancer. 2023. Vol. 129. No. 8. pp. 1195-1204.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1002/cncr.34657
UR - https://doi.org/10.1002/cncr.34657
TI - Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE‐158 study
T2 - Cancer
AU - Oh, Do-Youn
AU - Algazi, Alain
AU - Capdevila, Jaume
AU - Longo, Federico
AU - Miller, Wilson
AU - Chun Bing, Jerry Tan
AU - Bonilla, Carlos Eduardo
AU - Chung, Hyun Ung
AU - Guren, Tormod K
AU - Lin, Chia-Chi
AU - Motola-Kuba, Daniel
AU - Shah, Manisha
AU - Hadoux, Julien
AU - Yao, Lili
AU - Jin Fan
AU - Norwood, Kevin
AU - Lebellec, Loïc
PY - 2023
DA - 2023/02/07
PB - Wiley
SP - 1195-1204
IS - 8
VL - 129
PMID - 36748723
SN - 0008-543X
SN - 1097-0142
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2023_Oh,
author = {Do-Youn Oh and Alain Algazi and Jaume Capdevila and Federico Longo and Wilson Miller and Jerry Tan Chun Bing and Carlos Eduardo Bonilla and Hyun Ung Chung and Tormod K Guren and Chia-Chi Lin and Daniel Motola-Kuba and Manisha Shah and Julien Hadoux and Lili Yao and Jin Fan and Kevin Norwood and Loïc Lebellec},
title = {Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE‐158 study},
journal = {Cancer},
year = {2023},
volume = {129},
publisher = {Wiley},
month = {feb},
url = {https://doi.org/10.1002/cncr.34657},
number = {8},
pages = {1195--1204},
doi = {10.1002/cncr.34657}
}
Цитировать
MLA
Скопировать
Oh, Do-Youn, et al. “Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE‐158 study.” Cancer, vol. 129, no. 8, Feb. 2023, pp. 1195-1204. https://doi.org/10.1002/cncr.34657.